Comparison of circulating levels of interleukin-6 and tumor necrosis factor-alpha in hypertrophic cardiomyopathy and in idiopathic dilated cardiomyopathy

American Journal of Cardiology

Volumn 94, Issue 2, 2004, Pages 249-251

  Högye, Márta ^a   Mándi, Yvette ^a   Csanády, Miklós ^a   Sepp, Róbert ^a   Buzás, Krisztina ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; FEMALE; HEART LEFT VENTRICLE FAILURE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGED; CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR FUNCTION, LEFT;

EID: 3142564563     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.03.078     Document Type: Article

References (12)

1. MacGovan G.A., Mann D.L., Kérmos R.L., Feldman A.M., Murali S. Circulating IL-6 in severe heart failure. Am J Cardiol. 79:1997;1128-1131
2. Tsutamoto T., Hisanaga T., Wada A. Plasma concentration of interleukin-6 as a marker of prognosis in patients with chronic congestive heart failure. Circulation. 90:1994;381-390
3. Torre-Amione G., Kapadia S., Lee J., Durand J.B., Biews R.D., Young J.B., Mann D.L. Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart. Circulation. 93:1996;704-711
4. Kubota T., McTiernan C., Frye C., Stawson S., Lemster B., Koretsky A.P., Demetris A., Feldman A. Dilated cardiomyopathy in transgenic mice with cardiac specific overexpression of tumor necrosis factor-α Circ Res. 81:1997;627-636
5. Marriott J.B., Goldman J.H., Keeling P.J., Baig M.K., Dalgleish A.G., McKenna W.J. Abnormal cytokine profiles in patients with idiopathic dilated cardiomyopathy and their asymptomatic relatives. Heart. 75:1996;287-290
6. Matsumori A., Yamada T., Suzuki H., Matoba Y., Sasayama S. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J. 72:1994;561-566
7. Espevick T., Niessen-Meyer J.A. A highly sensitive cell line WEHI 164 for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods. 95:1986;99-105
8. Aarden L.A., deGroot E.R., Shaap O.L., Lansdorp P.M. Production of hybridoma growth factor by human monocytes. Eur J Immunol. 17:1987;1411-1416
9. Haegeman G., Content J., Volckaert G., Derynck R., Tavernier J., Fiers W. Structural analysis of the sequence encoding for an inducible 26-kDa protein in human fibroblasts. Eur J Biochem. 159:1986;625-632
10. Mándi Y., Högye M., Talha E.M., Skolák E., Csanády M. Cytokine production and antibodies against heat shock protein 60 in cardiomyopathies of different origins. Pathobiology. 68:2000;150-158
11. Tsutamoto A., Wada A., Ohnishi M., Tsutsui T., Ishii C., Ohno K., Fujii M., Matsumoto T., Yamamoto T., Takayama T., Dohke T., Horie M. Transcardiac increase in tumor necrosis factor-α and left ventricular end-diastolic volume in patients with dilated cardiomyopathy. Eur J Heart Fail. 6:2004;173-180
12. Waller K.C., Chien K.R. Cardiotrophin-1 and the role of gp130-dependent signaling pathways in cardiac growth and development. J Mol Med. 75:1997;492-501